Novartis Pharma acquires 49% stake in Chiron Behring Vaccines from Aventis Pharma - MarketLine Financial Deals

Novartis Pharma acquires 49% stake in Chiron Behring Vaccines from Aventis Pharma

Novartis Pharma acquires 49% stake in Chiron Behring Vaccines from Aventis Pharma - MarketLine Financial Deals
Novartis Pharma acquires 49% stake in Chiron Behring Vaccines from Aventis Pharma
Published Dec 23, 2010
3 pages — Published Dec 23, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Novartis Pharma AG has acquired a 49% stake in Chiron Behring Vaccines Private Limited (Chiron) from Aventis Pharma Limited.

  
Source:
Document ID
MA42458_101215
Country
Country
Country
Country
Ticker
500674=IN
Ticker
NOVN=CH
Ticker
SAN=FR
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Novartis Pharma acquires 49% stake in Chiron Behring Vaccines from Aventis Pharma" Dec 23, 2010. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novartis-Pharma-acquires-49-stake-in-Chiron-Behring-Vaccines-from-Aventis-Pharma-2052-49026>
  
APA:
MarketLine Financial Deals. (2010). Novartis Pharma acquires 49% stake in Chiron Behring Vaccines from Aventis Pharma Dec 23, 2010. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novartis-Pharma-acquires-49-stake-in-Chiron-Behring-Vaccines-from-Aventis-Pharma-2052-49026>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.